These results pave the path to NAP/ADNP enhancing therapy in the ADNP syndrome (CP201, Coronis Neurosciences) [68] and for NAP and related molecules as preventive treatment in prodromal AD [69]. The gene discussed is ADNP; the disease is ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder.